Reconstruction Over Exposed Structures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reconstruction over exposed structures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reconstruction Over Exposed Structures Today - Breaking & Trending Today

New U.S. Clinical Studies Provide Further Validation for Aroa Biosurgerys Myriad, as Products Also Approved for Use in India

Posted on
1116
Soft tissue regeneration company Aroa Biosurgery Limited (ASX:ARX, ‘Aroa’ or the ‘Company’) has gained further validation for Myriad™, a device for soft tissue reconstruction, with two studies published in successive months in a leading peer reviewed scientific journal, Journal of Wound Care, official journal of the European Wound Management Association (EWMA) and World Union of Wound Healing Societies (WUWHS).
A study published in the November 2020 edition of Journal of Wound Care showed 100% healing when Myriad™ was used in eight surgical reconstructions to address inflammatory skin condition Hidradenitis Suppurativa (HS). No major complications were reported out to three months, or longer. ....

United States , New Zealand , Brian Ward , Tela Bio , Simon Hinsley , Matthew Wright , Hidradenitis Suppurativa , American Society Of Plastic Surgeons , European Wound Management Association , National Clearinghouse Of Plastic Surgery Procedural Statistics , Australian Securities Exchange , Central Drugs Standard Control Organisation , Dr Maire Claire Buckley University Of Minnesota , World Union Of Wound Healing Societies , Aroa Biosurgery Limited , Tulane University Plastic Surgery Residency Program , Dr Abigail Chaffin Tulane University , Wound Care , World Union , Wound Healing Societies , Matrix Graft , Surgical Management , Hurley Stage , Pilot Case , Tulane University , New Orleans ,

New U.S. Clinical Studies Provide Further Validation for Aroa Biosurgery's Myriad™, as Products Also Approved for Use in India

Share:
HIGHLIGHTS
Further validation for Aroa s Myriad™ from two clinical studies and peer-reviewed publications in Journal of Wound Care.
One study shows high success rates, from use of Myriad™ in tissue reconstruction after surgical treatment of Hidradenitis Suppurativa, an inflammatory skin condition affecting around 1% of the adult population.
A second study showed 100% success rates from use of Myriad™ when patients underwent surgical reconstruction of exposed vital structures such as bone and tendon, demonstrating the utility of Myriad™ for both implant procedures and dermal reconstruction and across a wide range of surgical procedures.
The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Myriad™, Endoform® Natural and Endoform® Antimicrobial. India has significant market potential with a large volume of acute and chronic wounds and distribution expected to commence in second half of ....

United States , New Zealand , Brian Ward , Tela Bio , Hidradenitis Suppurativa , American Society Of Plastic Surgeons , European Wound Management Association , National Clearinghouse Of Plastic Surgery Procedural Statistics , Australian Securities Exchange , Central Drugs Standard Control Organisation , Dr Maire Claire Buckley University Of Minnesota , World Union Of Wound Healing Societies , Tulane University Plastic Surgery Residency Program , Aroa Biosurgery Limited , Dr Abigail Chaffin Tulane University , Wound Care , World Union , Wound Healing Societies , Matrix Graft , Surgical Management , Hurley Stage , Pilot Case , Tulane University , New Orleans , Associate Professor , Program Director ,